We firmly believe that the achievements of women in the field of hereditary eye diseases have to be made visible and acknowledged worldwide. For this reason, and to celebrate the International Women
Read more
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that it has appointed Didier Le Normand as Group CFO as well as General Manager of its...
Read more
Usher syndrome is a genetic disorder that presents recessive inheritance and is characterized by hearing loss and retinitis pigmentosa, traits that may be total or partial.
Read more
Results could help remove one of the barriers to treatment scale up and bring new hope for people with Chagas disease
Read more
For the third year in a row, the Leo Messi Foundation has renewed its collaboration with the Translational Research in Child and Adolescent Cancer group of the Vall d'Hebron Research Institute (VHIR)
Read more
El CIBERER ha liderado o participado en las 15 designaciones de medicamentos huérfanos de centros públicos españoles. Los grupos de este centro investigan en terapias para grupos de enfermedades co...
Read more
La UIB ha liderado el mayor ensayo clínico acerca de los efectos de diferentes estrategias nutricionales en la prevención del Trastorno Depresivo Mayor
Read more
Un estudio de la Universidad Pompeu Fabra revela nuevas interacciones entre lenguaje y pensamiento en la afasia, un trastorno del lenguaje que se produce como consecuencia de un accidente cerebrovascu...
Read more
Silvia Vicente, nurse at the Neonatal Intensive Care Unit (NICU) in San Pablo and member of the Care Research Group at the Sant Pau Biomedical Research Institute (IIB Sant Pau), has devised a device, ...
Read more
Una terapia basada en linfocitos modificados genéticamente ha mostrado resultados prometedores en un modelo de lupus eritematoso en ratón. La terapia, dirigida a eliminar los linfocitos B y minimiza...
Read more
Researchers from IDIBELL and ICO show that current mutational analysis techniques are sufficiently sensitive to predict resistance to treatment with EGFR inhibitors in metastatic colorectal cancer
Read more
Peptomyc S.L., spin-off nacida del VHIO, ha producido Omomyc, la miniproteína inhibidora de Myc, y demostrado su actividad antitumoral tras administrarla por vía sanguínea por primera vez. El estud...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
